Home Blood Pressure Telemonitoring + Community Health Worker Support for High Blood Pressure
(LINKED-BP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new program to manage high blood pressure (BP) through home monitoring and support from community health workers. One group will receive usual care with a home BP monitor, while the other will receive additional support, including training on BP measurement, use of a telemonitoring app, and lifestyle advice. The LINKED-BP Program targets adults with high BP who are not yet on medication and receive care at specific health centers. Individuals informed of higher-than-normal BP but not on treatment may find this trial suitable. As an unphased trial, this study provides a unique opportunity to explore innovative methods for managing high BP with personalized support.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those already on antihypertensive medication. If you are on such medication, you would not be eligible to participate.
What prior data suggests that this program is safe for managing high blood pressure?
Research has shown that the LINKED-BP Program helps individuals monitor their blood pressure at home using a telemonitoring app called Sphygmo. The program includes support from community health workers who provide education and lifestyle advice. These methods are well-known for managing high blood pressure.
Home blood pressure monitors and telemonitoring apps are generally safe. These tools are designed to be user-friendly and non-invasive. No reports of serious side effects or problems have emerged with this approach. Support from community health workers adds extra safety by offering guidance and helping participants understand how to manage their condition effectively.
As this is a "Not Applicable" phase trial, the study observes existing methods rather than testing a new drug. This indicates that the safety of these methods is already well understood, with no new treatment introduced that might have unknown risks.12345Why are researchers excited about this trial?
Researchers are excited about the LINKED-BP Program because it combines home blood pressure telemonitoring with personalized support from community health workers (CHWs), offering a fresh approach to managing high blood pressure. Unlike the standard care, which typically involves routine checkups and medication, this program empowers patients to actively monitor their blood pressure using a digital device and app, even providing smartphones to those who need them. The involvement of CHWs is particularly unique, as they offer ongoing education, support, and link patients to necessary resources, potentially addressing not just medical needs but social factors affecting health as well. This comprehensive, tech-enabled approach could lead to more effective blood pressure management and improved overall health outcomes.
What evidence suggests that this trial's treatments could be effective for high blood pressure?
Research has shown that the LINKED-BP Program, which participants in this trial may receive, can effectively manage high blood pressure. This program combines home blood pressure monitoring, a telemonitoring app called Sphygmo, and support from community health workers. This approach enables patients to regularly check their blood pressure and receive advice on lifestyle changes. Early results indicate that patients in this program achieve better blood pressure control than those in the Enhanced Usual Care arm, who only monitor their blood pressure at home. Thus, the LINKED-BP Program could be a promising method to prevent more serious high blood pressure.12456
Who Is on the Research Team?
Yvonne Commodore-Mensah, PhD, MHS, RN
Principal Investigator
JHU School Of Nursing
Are You a Good Fit for This Trial?
Adults over 18 with elevated blood pressure or untreated stage 1 hypertension, who are non-Hispanic white, African-American, or Hispanic and receive care at participating centers. Excluded are those on blood pressure meds, with end-stage renal disease, serious conditions like cancer, cognitive impairments, or an upper arm circumference >50 cm.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive training on home blood pressure monitoring, use of the Sphygmo telemonitoring app, and support from community health workers for lifestyle modification
Follow-up
Participants are monitored for changes in blood pressure and overall health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- LINKED-BP Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
American Heart Association
Collaborator